Care consumption of people with multiple sclerosis: A multichannel sequence analysis in a population-based setting in British Columbia, Canada
Jonathan Roux
,
Elaine Kingwell
,
Feng Zhu
,
Helen Tremlett
,
Emmanuelle Leray
et al.
Journal articles
hal-03246670v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Disease-modifying therapy usage in patients with multiple sclerosis in France: A 6-year population-based study
Soline Leblanc
,
Jonathan Roux
,
Hélène Tillaut
,
Emmanuelle Le Page
,
Emmanuelle Leray
et al.
Journal articles
hal-03312766v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Understanding heterogeneity in comparative effectiveness studies of natalizumab and fingolimod in multiple sclerosis: effect of analytical methodology
M. Lefort
,
S. Shannin
,
Jørgen Vitting Andersen
,
S. Vukusic
,
N. J. Koch-Henriksen
et al.
European Journal of Neurology , 2020, 27, pp.342-342
Journal articles
hal-02887182v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Trends in disease-modifying therapy use in patients with multiple sclerosis using a 10-year population-based cohort study in France
Soline Leblanc
,
Mathilde Lefort
,
Emmanuelle Le Page
,
Laure Michel
,
Emmanuelle Leray
et al.
Journal articles
hal-03629848v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Care-seeking of patients with multiple sclerosis over 2010-2015 in France - a nationwide study using health administrative data
Jonathan Roux
,
A. Guilleux
,
Olivier Grimaud
,
Emmanuelle Leray
Multiple Sclerosis Journal , 2018, 24, pp.550-551
Journal articles
hal-01935074v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Short-term exposure to ambient air pollution and occurrence of multiple sclerosis relapses
M. Jeanjean
,
M. -A. Bind
,
Jonathan Roux
,
J. -C. Ongagna
,
J. de Seze
et al.
Multiple Sclerosis Journal , 2017, 23, pp.209-210
Journal articles
hal-01715987v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Does air pollution influence risk of relapse in multiple sclerosis?
Emmanuelle Leray
,
E. Le Pabic
,
C. Fermanian
,
J. -C. Ongagna
,
Denis Bard
et al.
Multiple Sclerosis Journal , 2015, 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, SPAIN, OCT 07-10, 2015, 21 (11), pp.742--743
Journal articles
hal-01259394v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Determinants of Therapeutic Lag in Multiple Sclerosis
Izanne Roos
,
Emmanuelle Leray
,
Federico Frascoli
,
Romain Casey
,
J William L Brown
et al.
Journal articles
hal-03223056v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Benefits of homeopathic complementary treatment in patients with breast cancer: A retrospective cohort study based on the French nationwide healthcare database
J Medioni
,
D Scimeca
,
y Lopez Marquez
,
Emmanuelle Leray
,
M Dalichampt
et al.
Journal articles
hal-03820830v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Comorbidités mentales et sclérose en plaques : étude française à partir des données de l’Assurance maladie
A. Guilleux
,
Jonathan Roux
,
Emmanuelle Leray
Journal articles
hal-01740308v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Prevalence of mental disorders is higher in patients with multiple sclerosis than in the general population or in patients with rheumatoid arthritis in France
Alice Guilleux
,
Jonathan Roux
,
David Travers
,
Emmanuelle Leray
Multiple Sclerosis Journal - Experimental, Translational and Clinical , 2020, 6 (3), pp.2055217320941540.
⟨10.1177/2055217320941540⟩
Journal articles
hal-02960099v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Des différences d’état de santé mentale entre actifs, scolarisés et demandeurs d’emploi chez les 18–24ans, France
Emmanuelle Leray
,
L. Denis
,
Viviane Kovess-Masfety
Epidemiology and Public Health = Revue d'Epidémiologie et de Santé Publique , 2013, 61 (Supplement 4), pp.S270-S271.
⟨10.1016/j.respe.2013.07.214⟩
Journal articles
hal-04021827v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
La survenue de poussées de sclérose en plaques influencée par le niveau de particules fines PM10 dans l’air
Emmanuelle Leray
,
Estelle Le Pabic
,
J. Roux
,
Jean-Claude Ongagna
,
Denis Bard
et al.
Journal articles
hal-01740319v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Effets antagonistes de l’éducation et du revenu sur le risque d’accident vasculaire cérébral ischémique au sein d’une cohorte de personnes âgées
Olivier Grimaud
,
Emmanuelle Leray
,
A. Alperovitch
,
C. Dufouil
,
P. Chauvin
et al.
Journal articles
hal-04021795v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
High and low efficacy therapy in secondary progressive multiple sclerosis
I. Roos
,
E. Leray
,
K. Buzzard
,
O. Skibina
,
J. Lechner-Scott
et al.
Multiple Sclerosis Journal , 2022, 28, pp.6-6
Journal articles
hal-04056219v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Glossaire d’épidémiologie. 50 notions pour comprendre la pandémie de Covid-19
Mélanie Bertin
,
Pascal Crepey
,
Olivier Grimaud
,
Nolwenn Le Meur
,
Emmanuelle Leray
et al.
Books
hal-03312283v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Mortality following stroke during and after acute care according to neighbourhood deprivation: a disease registry study
Olivier Grimaud
,
Emmanuelle Leray
,
Benoît Lalloué
,
Radouane Aghzaf
,
Jérôme Durier
et al.
Journal articles
hal-02436963v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Clinically definite benign multiple sclerosis', an unwarranted conceptual hodgepodge: evidence from a 30-year observational study.
Emmanuelle Leray
,
M. Coustans
,
Emmanuelle Le Page
,
J. Yaouanq
,
Joel Oger
et al.
Journal articles
hal-00878705v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Criteria improving multiple sclerosis diagnosis at the first MRI
Nathalie Caucheteux
,
Adil Maarouf
,
Margaux Genevray
,
Emmanuelle Leray
,
Romain Deschamps
et al.
Journal articles
hal-01378308v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Comparaison des anti-CD20 et du natalizumab chez des patients avec une SEP très active
Fabien Rollot
,
Couturier Justine
,
Romain Casey
,
Emmanuelle Leray
,
Sandra Vukusic
et al.
Journal articles
hal-03820845v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Descriptif des caractéristiques des personnes ayant une sclérose en plaques en France et de leur recours aux soins à partir du Système National des Données de Santé en 2010-2015
Jonathan Roux
,
Alice Guilleux
,
Mathilde Lefort
,
Emmanuelle Leray
Journal articles
hal-02921515v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Use of administrative database to describe physician services utilization and care patterns in multiple sclerosis in France
Emmanuelle Leray
,
J. Roux
,
N Le Meur
Conference papers
hal-01228174v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
An excessive risk of suicide may no longer be a reality for multiple sclerosis patients
Shoshannah Kalson-Ray
,
Gilles Edan
,
Emmanuelle Leray
Journal articles
hal-01518889v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Epidemiology of multiple sclerosis
Emmanuelle Leray
,
Thibault Moreau
,
Agnès Fromont
,
Gilles Edan
Journal articles
hal-01255824v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Multiple sclerosis: effect of beta interferon treatment on survival
Elaine Kingwell
,
Emmanuelle Leray
,
Feng Zhu
,
John Petkau
,
Gilles Edan
et al.
Journal articles
hal-02088095v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Use of healthcare services by patients with multiple sclerosis in France over 2010-2015: a nationwide population-based study using health administrative data
Jonathan Roux
,
Alice Guilleux
,
Mathilde Lefort
,
Emmanuelle Leray
Multiple Sclerosis Journal - Experimental, Translational and Clinical , 2019, 5 (4), pp.2055217319896090.
⟨10.1177/2055217319896090⟩
Journal articles
hal-02444012v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Ozone, NO2 and PM10 are associated with the occurrence of multiple sclerosis relapses. Evidence from seasonal multi-pollutant analyses
Maxime Jeanjean
,
Marie-Abele Bind
,
Jonathan Roux
,
Jean-Claude Ongagna
,
Jérôme de Sèze
et al.
Journal articles
hal-01740486v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis
David-Axel Laplaud
,
Romain Casey
,
Laetitia Barbin
,
Marc Debouverie
,
Jerome de Sèze
et al.
Journal articles
inserm-02289153v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Assessing the cumulative effects of disease-modifying therapies on the current risk of irreversible disability in patients with relapsing-remitting multiple sclerosis
F. Rollot
,
Romain Casey
,
Marc Debouverie
,
Gilles Edan
,
S. Wiertlewski
et al.
Multiple Sclerosis Journal , 2018, 24, pp.344-345
Journal articles
hal-01935071v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Immunization and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society
C. Lebrun
,
S. Vukusic
,
V. Abadie
,
C. Achour
,
F. Ader
et al.
Journal articles
hal-02546158v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More